Amphetamines and Derivatives

Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, Fourth Edition

Volumn , Issue , 2007, Pages 781-792

  Albertson, Timothy E ^a,b,c   Kenyon, Nicholas J ^a   Morrissey, Brian ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Internal Medicine Division of Pulmonary Critical Care Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886348868     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0693-4.50049-9     Document Type: Chapter

References (108)

1. AK Cho (1990) Ice: a new dosage form of an old drug. Science 249 631-634.
2. FH Gawin and EH Ellinwood Jr (1988) Cocaine and other stimulants: actions, abuse, and treatment. N Engl J Med 318 1173-1182.
3. G Piness, H Miller and GA Alles (1930) Clinical observations on phenylaminoethanol sulfate. JAMA 94 790-791.
4. RJ Anderson, WG Reed, LD Hillis, et al. (1982) History, epidemiology, and medical complications of nasal inhaler abuse. J Toxicol Clin Toxicol 19 95-107.
5. A Myerson (1936) Effect of benzedrine sulphate on mood and fatigue in normal and in neurotic persons. Arch Neurol Psychiatry 36 816-822.
6. RW Derlet and B Heischober (1990) Methamphetamine. Stimulant of the 1990s? West J Med 153 625-628.
7. CH Linden, KW Kulig and BH Rumack (1985) Amphetamines. Top Emerg Med 7 18-32.
8. W Klein-Schwartz (2002) Abuse and toxicity of methylphenidate. Curr Opin Pediatr 14 219-223.
9. EH Ellinwood Jr (1971) Assault and homicide associated with amphetamine abuse. Am J Psychiatry 127 1170-1175.
10. H Kalant and OJ Kalant (1975) Death in amphetamine users: causes and rates. Can Med Assoc J 112 299-304.
11. S Katsumata, K Sato, H Kashiwade, et al. (1993) Sudden death due presumably to internal use of methamphetamine. Forensic Sci Int 62 209-215.
12. DN Bailey and RF Shaw (1989) Cocaine- and methamphetamine-related deaths in San Diego County (1987): homicides and accidental overdoses. J Forensic Sci 34 407-422.
13. DK Beebe and E Walley (1995) Smokable methamphetamine (“ice”): an old drug in a different form. Am Fam Physician 51 449-453.
14. DN Bailey (1987) Amphetamine detection during toxicology screening of a university medical center patient population. J Toxicol Clin Toxicol 25 399-409.
15. L Wermuth (2000) Methamphetamine use: hazards and social influences. J Drug Educ 30 423-433.
16. DG Caldicott, NA Edwards, A Kruys, et al. (2003) Dancing with “death”: p-methoxyamphetamine overdose and its acute management. J Toxicol Clin Toxicol 41 143-154.
17. JC Kraner, DJ McCoy, MA Evans, et al. (2001) Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA). J Anal Toxicol 25 645-648.
18. TL Martin (2001) Three cases of fatal paramethoxyamphetamine overdose. J Anal Toxicol 25 649-651.
19. U.S. Drug Enforcement Agency: http://www.dea.gov/pubs/states/california.html. Accessed 1/6/05.
20. RA Rawson, R Gonzales and P Brethen (2002) Treatment of methamphetamine use disorders: an update. J Subst Abuse Treat 23 145-150.
21. RC Baselt and RH Cravey (1995) Amphetamine. Disposition of Toxic Drugs and Chemicals in Man Foster City, CA: Chemical Toxicology Insitute 44-47.
22. JS Markowitz, CL DeVane, DW Boulton, et al. (2000) Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. Drug Metab Dispos 28 620-624.
23. JS Markowitz, BK Logan, F Diamond and KS Patrick (1999) Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion. J Clin Psychopharmacol 19 362-366.
24. J Mendelson, RT Jones, R Upton and P Jacob III (1995) Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther 57 559-568.
25. JC Kramer, VS Fischman and DC Littlefield (1967) Amphetamine abuse: pattern and effects of high doses taken intravenously. JAMA 201 305-309.
26. DE Smith and CM Fischer (1970) An analysis of 310 cases of acute high-dose methamphetamine toxicity in Haight-Ashbury. Clin Toxicol 3 117-124.
27. RW Derlet, P Rice, BZ Horowitz and RV Lord (1989) Amphetamine toxicity: experience with 127 cases. J Emerg Med 7 157-161.
28. TE Robinson and JB Becker (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396 157-198.
29. M Sato (1992) A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci 654 160-170.
30. EH Ellinwood (1967) Amphetamine Psychosis. 1. Description of the individuals and process. J Nerv Ment Dis 144 273-283.
31. DS Bell (1973) The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 29 35-40.
32. SE Polchert and RM Morse (1985) Pemoline abuse. JAMA 254 946-947.
33. S Castellani, W Petrie and E Ellinwood (1985) Drug-induced psychosis: neurobiological mechanisms. A Alterman (Ed.) Substance Abuse and Psychopathology New York: Plenum Press 173-210.
34. MD Schechter and RA Glennon (1985) Cathinone, cocaine and methamphetamine: similarity of behavioral effects. Pharmacol Biochem Behav 22 913-916.
35. GP Dowling, ET McDonough and RO Bost (1987) “Eve” and “Ecstasy”: a report of five deaths associated with the use of MDEA and MDMA. JAMA 257 1615-1617.
36. WR Dubin, KJ Weiss and JM Dorn (1986) Pharmacotherapy of psychiatric emergencies. J Clin Psychopharmacol 6 210-222.
37. CM Meston and BB Gorzalka (1992) Psychoactive drugs and human sexual behavior: the role of serotonergic activity. J Psychoactive Drugs 24 1-40.
38. SM Kuniyoshi and J Jankovic (2003) MDMA and parkinsonism. N Engl J Med 349 96-97.
39. JS Fowler and ND Volkow (1998) PET imaging studies in drug abuse. J Toxicol Clin Toxicol 36 163-174.
40. HL Klawans and WJ Weiner (1976) The pharmacology of choreatic movement disorders. Prog Neurobiol 6 49-80.
41. KJ Rhee, TE Albertson and JC Douglas (1988) Choreoathetoid disorder associated with amphetamine-like drugs. Am J Emerg Med 6 131-133.
42. H Lundh and K Tunving (1981) An extrapyramidal choreiform syndrome caused by amphetamine addiction. J Neurol Neurosurg Psychiatry 44 728-730.
43. JA Henry, KJ Jeffreys and S Dawling (1992) Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 340 384-387.
44. D Simpson and B Rumack (1987) Methylenedioxyamphetamine clinical description of overdose, death, and review of pharmacology. Arch Intern Med 141 1507-1509.
45. P Chan, JH Chen, MH Lee and JF Deng (1994) Fatal and nonfatal methamphetamine intoxication in the intensive care unit. J Toxicol Clin Toxicol 32 147-155.
46. SA Lukes (1983) Intracerebral hemorrhage from an arteriovenous malformation after amphetamine injection. Arch Neurol 40 60-61.
47. V Salanova and R Taubner (1984) Intracerebral haemorrhage and vasculitis secondary to amphetamine use. Postgrad Med J 60 429-430.
48. H Matick, D Anderson and J Brumlik (1983) Cerebral vasculitis associated with oral amphetamine overdose. Arch Neurol 40 253-254.
49. JC Hughes, M McCabe and RJ Evans (1993) Intracranial haemorrhage associated with ingestion of “ecstasy.”. Arch Emerg Med 10 372-374.
50. F Conci, V D'Angelo, D Tampieri and G Vecchi (1988) Intracerebral hemorrhage and angiographic beading following amphetamine abuse. Ital J Neurol Sci 9 77-81.
51. JU Brorholt-Petersen and HR Christensen (2000) (Fatal intracerebral hemorrhage after amphetamine intake). Ugeskr Laeger 162 4156-4157.
52. JF Rothrock, R Rubenstein and PD Lyden (1988) Ischemic stroke associated with methamphetamine inhalation. Neurology 38 589-592.
53. SM Gospe Jr (1995) Transient cortical blindness in an infant exposed to methamphetamine. Ann Emerg Med 26 380-382.
54. C Davidson, AJ Gow, TH Lee and EH Ellinwood (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 36 1-22.
55. SJ Lester, M Baggott, S Welm, et al. (2000) Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann Intern Med 133 969-973.
56. MA Khan, CA Herzog, JV St Peter, et al. (1998) The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med 339 713-718.
57. NJ Weissman, JF Tighe Jr, JS Gottdiener and JT Gwynne (1998) An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. N Engl J Med 339 725-732.
58. RB Devereux (1998) Appetite suppressants and valvular heart disease. N Engl J Med 339 765-766.
59. H Jick, C Vasilakis, LA Weinrauch, et al. (1998) A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. N Engl J Med 339 719-724.
60. JM Gardin, D Schumacher, G Constantine, et al. (2000) Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine. JAMA 283 1703-1709.
61. CC Wee, RS Phillips, G Aurigemma, et al. (1998) Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication. Ann Intern Med 129 870-874.
62. GG Davis and CI Swalwell (1994) Acute aortic dissections and ruptured berry aneurysms associated with methamphetamine abuse. J Forensic Sci 39 1481-1485.
63. SR Furst, SP Fallon, GN Reznik and PK Shah (1990) Myocardial infarction after inhalation of methamphetamine (letter). N Engl J Med 323 1147-1148.
64. MD Sztajnkrycer, S Hariharan and GR Bond (2002) Cardiac irritability and myocardial infarction in a 13-year-old girl following recreational amphetamine overdose. Pediatr Emerg Care 18 E11-E15.
65. WH Frishman, A Del Vecchio, S Sanal and A Ismail (2003) Cardiovascular manifestations of substance abuse. 2. Alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Dis 5 253-271.
66. R Hong, E Matsuyama and K Nur (1991) Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 265 1152-1154.
67. CI Swalwell and GG Davis (1999) Methamphetamine as a risk factor for acute aortic dissection. J Forensic Sci 44 23-26.
68. TE Albertson, WF Walby and RW Derlet (1995) Stimulant-induced pulmonary toxicity. Chest 108 1140-1149.
69. RA Schmidt, RW Glenny, JD Godwin, et al. (1991) Panlobular emphysema in young intravenous Ritalin abusers. Am Rev Respir Dis 143 649-656.
70. CB Sherman, LD Hudson and DJ Pierson (1987) Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers. Chest 92 1085-1087.
71. JP Pare, G Cote and RS Fraser (1989) Long-term follow-up of drug abusers with intravenous talcosis. Am Rev Respir Dis 139 233-241.
72. E Maury, JM Darondel, A Buisinne, et al. (1999) Acute pulmonary edema following amphetamine ingestion. Intensive Care Med 25 332-333.
73. KL Huang, KP Shaw, D Wang, et al. (2002) Free radicals mediate amphetamine-induced acute pulmonary edema in isolated rat lung. Life Sci 71 1237-1244.
74. N Nishida, N Ikeda, K Kudo and R Esaki (2003) Sudden unexpected death of a methamphetamine abuser with cardiopulmonary abnormalities: a case report. Med Sci Law 43 267-271.
75. PH Schaiberger, TC Kennedy, FC Miller, et al. (1993) Pulmonary hypertension associated with long-term inhalation of “crank” methamphetamine. Chest 104 614-616.
76. WC Kendrick, AR Hull and JP Knochel (1977) Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med 86 381-387.
77. CW Callaway and RF Clark (1994) Hyperthermia in psychostimulant overdose. Ann Emerg Med 24 68-76.
78. ME Wallace and R Squires (2000) Fatal massive amphetamine ingestion associated with hyperpyrexia. J Am Board Fam Pract 13 302-304.
79. SA Burchell, HC Ho, M Yu and DR Margulies (2000) Effects of methamphetamine on trauma patients: a cause of severe metabolic acidosis? Crit Care Med 28 2112-2115.
80. AL Jones, DR Jarvie, G McDermid and AT Proudfoot (1994) Hepatocellular damage following amphetamine intoxication. J Toxicol Clin Toxicol 32 435-444.
81. V Andreu, A Mas, M Bruguera, et al. (1998) Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 29 394-397.
82. M Shannon (2000) Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pediatr Emerg Care 16 377-380.
83. CA Schirren, TM Berghaus and M Sackmann (1999) Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver failure. Ann Intern Med 130 163.
84. TD Johnson and MM Berenson (1991) Methamphetamine-induced ischemic colitis. J Clin Gastroenterol 13 687-689.
85. RE Pecha, T Prindiville, BS Pecha, et al. (1996) Association of cocaine and methamphetamine use with giant gastroduodenal ulcers. Am J Gastroenterol 91 2523-2527.
86. LJ Deloach-Banta (1994) Lichenoid drug eruption: crystal methamphetamine or adulterants? Cutis 53 97-98.
87. MA Cadier and JA Clarke (1993) Ecstasy and Whizz at a rave resulting in a major burn plus complications. Burns 19 239-240.
88. SD Dixon (1989) Effects of transplacental exposure to cocaine and methamphetamine on the neonate. West J Med 150 436-442.
89. VA Catanzarite and DA Stein (1995) “Crystal” and pregnancy—methamphetamine-associated maternal deaths. West J Med 162 454-457.
90. JL Stewart and JE Meeker (1997) Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol 21 515-517.
91. MM Werler, JE Sheehan and AA Mitchell (2003) Association of vaso-constrictive exposures with risks of gastroschisis and small intestinal atresia. Epidemiology 14 349-354.
92. V Lekskulchai and C Mokkhavesa (2001) Evaluation of Roche Abuscreen ONLINE amphetamine immunoassay for screening of new amphetamine analogues. J Anal Toxicol 25 471-475.
93. JL Valentine and R Middleton (2000) GC-MS identification of sympathomimetic amine drugs in urine: rapid methodology applicable for emergency clinical toxicology. J Anal Toxicol 24 211-222.
94. A Smith-Kielland, B Skuterud and J Morland (1997) Urinary excretion of amphetamine after termination of drug abuse. J Anal Toxicol 21 325-359.
95. JE Meeker and PC Reynolds (1990) Postmortem tissue methamphetamine concentrations following selegiline administration. J Anal Toxicol 14 330-331.
96. JA Tarver (1994) Amphetamine-positive drug screens from use of clobenzorex hydrochlorate. J Anal Toxicol 18 183.
97. JS Chappell (1997) Infrared discrimination of enantiomerically enriched and racemic samples of methamphetamine salts. Analyst 122 755-760.
98. C Fang, YL Chung, JT Liu and CH Lin (2002) Rapid analysis of 3,4-methylenedioxymethamphetamine: a comparison of nonaqueous capillary electrophoresis/fluorescence detection with GC/MS. Forensic Sci Int 125 142-148.
99. Y Nakahara and R Kikura (1997) Hair analysis for drugs of abuse. 18. 3,4-Methylenedioxymethamphetamine (MDMA) disposition in hair roots and use in identification of acute MDMA poisoning. Biol Pharm Bull 20 969-972.
100. J Rohrich and G Kauert (1997) Determination of amphetamine and methylenedioxy-amphetamine-derivatives in hair. Forensic Sci Int 84 179-188.
101. R Kronstrand, R Grundin and J Jonsson (1998) Incidence of opiates, amphetamines, and cocaine in hair and blood in fatal cases of heroin overdose. Forensic Sci Int 92 29-38.
102. P Kintz and V Cirimele (1997) Interlaboratory comparison of quantitative determination of amphetamine and related compounds in hair samples. Forensic Sci Int 84 151-156.
103. PE McKinney, C Tomaszewski, S Phillips, et al. (1994) Methamphetamine toxicity prevented by activated charcoal in a mouse model. Ann Emerg Med 24 220-223.
104. NE Gary and P Saidi (1978) Methamphetamine intoxication: a speedy new treatment. Am J Med 64 537-540.
105. Lead poisoning associated with intravenous-methamphetamine use—Oregon, 1988. MMWR Morb Mortal Wkly Rep 38 830-831.
106. CE Sandrock and S Murin (2001) Clinical predictors of respiratory failure and long-term outcome in black tar heroin-associated wound botulism. Chest 120 562-566.
107. A Hutchaleelaha and M Mayersohn (1996) Influence of activated charcoal on the disposition kinetics of methamphetamine enantiomers in the rat following intravenous dosing. J Pharm Sci 85 541-545.
108. KM Kantak (2003) Vaccines against drugs of abuse: a viable treatment option? Drugs 63 341-352.